fax: 858-534-3338. (fattyliver.ucsd.edu)
Steatohepatitis/Metabolic Liver Disease
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial †
Article first published online: 2 JUL 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 56, Issue 3, pages 922–932, September 2012
How to Cite
Le, T.-A., Chen, J., Changchien, C., Peterson, M. R., Kono, Y., Patton, H., Cohen, B. L., Brenner, D., Sirlin, C., Loomba, R. and for the San Diego Integrated NAFLD Research Consortium (SINC) (2012), Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial . Hepatology, 56: 922–932. doi: 10.1002/hep.25731
Potential conflict of interest: Nothing to report.
- Issue published online: 28 AUG 2012
- Article first published online: 2 JUL 2012
- Accepted manuscript online: 20 MAR 2012 12:00AM EST
- Manuscript Accepted: 9 MAR 2012
- Manuscript Received: 15 JAN 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_25731_sm_SuppTab1.doc||209K||Supporting Information Table 1. CONSORT 2010 checklist of information to include when reporting a randomised trial*|
|HEP_25731_sm_SuppTab2.doc||50K||Supporting Information Table 2: Adverse events in colesevelam and placebo groups.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.